Literature DB >> 28811239

Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study.

Setor K Kunutsor1, Jari A Laukkanen2.   

Abstract

BACKGROUND: Elevated serum gamma-glutamyltransferase (GGT) activity has been linked with an increased risk of chronic kidney disease (CKD) in Asian populations. We aimed to assess the prospective association of serum GGT with risk of CKD in a Caucasian population.
MATERIALS AND METHODS: We related GGT activity to the incidence of CKD in 2338 men aged 42-61years of the Kuopio Ischemic Heart Disease study with normal kidney function at baseline. Repeat measurements of GGT were used to correct for within-person variability.
RESULTS: During a median follow-up of 25.6years, 221 men developed new-onset CKD. The age-adjusted regression dilution ratio of loge GGT was 0.70 (95% CI: 0.64-0.75). Gamma-glutamyltransferase was log-linearly associated with risk of CKD in age-adjusted analysis. In Cox regression analysis adjusted for age, the hazard ratio (95% CIs) for CKD per standard deviation increase in loge baseline GGT was 1.25 (1.09-1.43) which was attenuated to 1.01 (0.86-1.19) on further adjustment for several confounders.
CONCLUSION: Contrary to previous evidence of an independent association between elevated GGT and increased risk of CKD in Asian populations, initial evidence of an association between GGT and CKD in Caucasian men was confounded by body mass index, lifestyle factors, and lipids.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Cohort study; Gamma-glutamyltransferase; Risk factor

Mesh:

Substances:

Year:  2017        PMID: 28811239     DOI: 10.1016/j.cca.2017.08.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.

Authors:  Haesuk Park; Ghadeer K Dawwas; Xinyue Liu; Mindie H Nguyen
Journal:  J Intern Med       Date:  2019-08-23       Impact factor: 8.989

Review 2.  Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect.

Authors:  Rajiv Heda; Masahiko Yazawa; Michelle Shi; Madhu Bhaskaran; Fuad Zain Aloor; Paul J Thuluvath; Sanjaya K Satapathy
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

3.  Evaluation of Homocysteine and Gamma-Glutamyl Transferase Concentrations As Markers of Chronic Kidney Disease: An Indian Perspective.

Authors:  Shyamkrishnan R; Gautom K Saharia; Sandip Panda; Manaswini Mangaraj
Journal:  Cureus       Date:  2022-03-08

4.  Gamma-glutamyl transferase variability can predict the development of end-stage of renal disease: a nationwide population-based study.

Authors:  Da Young Lee; Kyungdo Han; Ji Hee Yu; Sanghyun Park; Jee-In Heo; Ji A Seo; Nam Hoon Kim; Hye Jin Yoo; Sin Gon Kim; Seon Mee Kim; Kyung Mook Choi; Sei Hyun Baik; Yong Gyu Park; Nan Hee Kim
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

5.  Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study.

Authors:  Mikiko Shibata; Kyoko Kogawa Sato; Shinichiro Uehara; Hideo Koh; Keiko Oue; Hiroshi Kambe; Michio Morimoto; Tomoshige Hayashi
Journal:  J Epidemiol       Date:  2019-03-30       Impact factor: 3.211

6.  Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study.

Authors:  Sandawana William Majoni; Federica Barzi; Wendy Hoy; Richard J MacIsaac; Alan Cass; Louise Maple-Brown; Jaquelyne T Hughes
Journal:  BMC Nephrol       Date:  2020-12-01       Impact factor: 2.388

7.  Expression Status and Prognostic Significance of Gamma-Glutamyl Transpeptidase Family Genes in Hepatocellular Carcinoma.

Authors:  Shan Tian; Jiao Li; Yingyun Guo; Weiguo Dong; Xin Zheng
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

8.  CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma.

Authors:  Shao-Cheng Lyu; Jing Wang; Mengxiu Huang; Han-Xuan Wang; Lin Zhou; Qiang He; Ren Lang
Journal:  Cancer Manag Res       Date:  2021-06-21       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.